Device Trial Radar · NCT01525134
Feasibility of a Lateral Flow Urine Lipoarabinomannan (LAM) Test for Diagnosis of Tuberculosis
Last checked: Nov 20, 2026Latest source record: Feb 2, 2012 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
504
Actual
Start
Jan 2011
Primary completion
Feb 2012
Study completion Apr 2012
Sponsor
- Lead sponsor
- Tuberculosis Clinical Diagnostics Research ConsortiumResearch network
- Sponsor type
- Research network
- Collaborators
- Makerere University
- First posted
- Feb 2, 2012
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the accuracy, diagnostic yield, operational performance, and time to diagnosis of a novel lateral-flow urine lipoarabinomannan (LAM) test in detecting tuberculosis in HIV-infected adults. A secondary study objective is to determine the accuracy, efficiency, costs, and cost-effectiveness of various combinations of Tuberculosis (TB) diagnostic tests, including the novel Xpert MTB/Rif test.
Conditions
- Tuberculosis
- Tuberculosis, Pulmonary
- Tuberculosis, Miliary
Interventions
Alere "Determine" lateral-flow urine lipoarabinomannan assayDevice
lateral-flow (point-of-care) urine test to detect the lipoarabinomannan (LAM) component of the M. tuberculosis antigen in the urine of TB suspects, in vitro. Manufacturer: Alere
Alere "Clearview" ELISA urine LAM assayDevice
ELISA-based urine test to detect the lipoarabinomannan component of the M. tuberculosis antigen in the urine of TB suspects, in vitro. Manufacturer: Alere.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Sensitivity of the lateral-flow urine LAM assay (LF-LAM)Time frame: One year
- Failure rate of the lateral-flow urine LAM assayTime frame: One year
- Inter-reader variability of the lateral-flow urine LAM assayTime frame: One year
1 more outcomes with a free account
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Infectious Diseases Institute, Makerere University
Kampala, Uganda
Mulago National Referral Hospital
Kampala, Uganda
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.